Additional Information for Reliv Organix

BBB promotes truth in advertising by contacting advertisers whose claims conflict with the BBB Code of Advertising.  These claims may come to our attention from our internal review of advertising, consumer complaints and competitor challenges.  BBB asks advertisers to prove their claims, change ads to make offers more clear to consumers, and remove misleading or deceptive statements.

On June 24, 2022, BBB contacted Reliv Organix regarding advertised health and disease claims on their website https://relivorganix.com.

Reliv Organix advertises their CBD products offer anxiety relief, pain relief, restrict the growth of cancer cells, treat skin conditions such as psoriasis, and reduce seizures as some of the benefits of CBD.

BBB Code of Advertising states claims relating to performance, energy savings, safety, efficacy or results for a product or service should be based on recent and competent testing or other objective data. 

BBB requested Reliv Organix to substantiate the advertised claims by providing competent, recent, and reliable studies or other objective data substantiating the advertised claims to treat or otherwise provide health benefits. If the claims could not be substantiated BBB requested Reliv Organix to discontinue the advertisements.  

As of July 26, 2022, Reliv Organix failed to respond to BBB's requests.